Share

    


Home / Search Results

Search Results

You searched for:

    Displaying results 1 - 20 of 27
  • 1
  • 2
  • »
The shortage of chemotherapy drugs is placing a considerable burden on cancer care providers. To end this, ACCC is working its members, as well as other provider and patient advocacy organizations, to identify potential policy solutions.
Ochsner Health, Ochsner Cancer Institute developed a program to remotely monitor patients on intravenous or oral anti-cancer treatment.
The increase in incidents of cardiotoxicity due to a number of cancer treatment modalities necessitates the need for cardio-oncology.
The HealthPartners Frauenshuh Cancer Center has safely incorporated cannabis in the treatment of patients with cancer.
Learn the 10 feasible and impactful “how-tos” Summit participants identified within three domains—care coordination and communication, clinical trials, and acknowledging and mitigating implicit bias.
Regardless of the reason, the ability to bill for discontinued services will depend on why the service had to be stopped and how it was addressed.
An expert ACCC Steering Committee shares 32 informed treatment and care delivery recommendations for the ideal care of patients with non-small cell lung cancer.
In addition to the global pandemic, ongoing lawsuits from referenced biologics' manufacturers suing biosimilar manufacturers are having a negative impact on the development and approval of new biosimilars.
This ACCC education program shares key highlights from a national survey of thoracic surgeons, radiation oncologists, and medical oncologists on the barriers that exist in the ideal management of patients with NSCLC.
Providers and staff at the University of Arizona Cancer Center, along with published literature, report that patients want to receive their therapies in the outpatient setting when possible
Dr. Vijay Rao and Dr. Eric Stephen Rubenstein returned from a Global Cardio-Oncology Society meeting g with the realization that they could do much more to protect patients with cancer from potential cardiac toxicity of chemotherapy. The two shared one goal: to prevent the cancer survivor of today from becoming the heart failure patient of tomorrow.
In response to the increasing complexity of oncolytic agents, the associated economic burden on the patient and health system, and the intricacies associated with alternative payment models (APMs), I suggest the need for widespread establishment of chemotherapy stewardship services.
Learn how Advocate-Aurora Lutheran General Hospital, Ill., modified an unused space in its inpatient oncology unit to create an outpatient oncology symptom management treatment area. The program now sees cancer patients outside of traditional office hours, thereby reducing ED visits and hospitalizations.
Understanding both a patient’s need for support during the cancer journey and the importance for medical students to personally connect with those they care for led to the creation of Chemo Companions in 2016. Through this program, students assume a companion/support role with cancer patients currently receiving chemotherapy at one of Mount Sinai’s cancer centers.
With this dynamic change in treatment modalities comes a need to change our practice models to keep pace with innovation, quality care, and patient needs.
Although many rural facilities in South Dakota do have infusion centers that administer anti-cancer therapies, these centers are generally not directly overseen by an oncologist or oncology trained advanced practice provider. Rather, local family practice or internal medicine physicians who are often unfamiliar with oncologic therapies oversee the administration of infusions.
In the Department of Pharmacy at the University of North Carolina North Carolina Cancer Hospital, discarding partial drug vials was a significant source of waste. With their Innovator Award–winning drug vial optimization program, the program maximized the lifespan of drugs within single-dose vials and realized an annual cost savings of more than $40 million.
The complexity of head and neck cancer management demands greater attention in order to provide high-quality care. UC San Diego Moores Cancer Center developed a well-defined care pathway to enable predictability and consistency in both care delivery and cost.
The Association of Community Cancer Centers (ACCC) recently hosted live continuing medical education (CME)-certified learning workshops at two community cancer programs to review current barriers to immunotherapy implementation in the community setting. During the workshops, an expert faculty panel engaged participants in discussion on the challenges that they may face as they integrate immunotherapy …
Fertility preservation is an increasing concern for adolescent and young adult (AYA) patients with cancer. However, not all newly diagnosed males discuss fertility preservation with a healthcare provider before treatment. This quality improvement project describes the oncofertility program development that was part of a larger goal to develop an AYA oncology program at our institution, the University …
    Displaying results 1 - 20 of 27
  • 1
  • 2
  • »